Analysis of Target Volume Definition Using CT, MRI and FDG-PET in Radiotherapy Treatment Planning of Anal Cancer

Publication: Research - peer-reviewConference abstract in journal – Annual report year: 2012

Standard

Analysis of Target Volume Definition Using CT, MRI and FDG-PET in Radiotherapy Treatment Planning of Anal Cancer. / Serup-Hansen, E.; Hendel, H. Westergreen ; Johannesen, H. Hjorth ; Ottosson, W.; Kristensen, B.; Hollensen, Christian; Persson, G. Fredberg ; Geertsen, P. F. ; Havsteen, H.

In: Radiotherapy & Oncology, Vol. 103, No. Supplement 1, 2012, p. S305.

Publication: Research - peer-reviewConference abstract in journal – Annual report year: 2012

Harvard

Serup-Hansen, E, Hendel, HW, Johannesen, HH, Ottosson, W, Kristensen, B, Hollensen, C, Persson, GF, Geertsen, PF & Havsteen, H 2012, 'Analysis of Target Volume Definition Using CT, MRI and FDG-PET in Radiotherapy Treatment Planning of Anal Cancer' Radiotherapy & Oncology, vol 103, no. Supplement 1, pp. S305., 10.1016/S0167-8140(12)71120-9

APA

Serup-Hansen, E., Hendel, H. W., Johannesen, H. H., Ottosson, W., Kristensen, B., Hollensen, C., ... Havsteen, H. (2012). Analysis of Target Volume Definition Using CT, MRI and FDG-PET in Radiotherapy Treatment Planning of Anal Cancer. Radiotherapy & Oncology, 103(Supplement 1), S305. 10.1016/S0167-8140(12)71120-9

CBE

Serup-Hansen E, Hendel HW, Johannesen HH, Ottosson W, Kristensen B, Hollensen C, Persson GF, Geertsen PF, Havsteen H. 2012. Analysis of Target Volume Definition Using CT, MRI and FDG-PET in Radiotherapy Treatment Planning of Anal Cancer. Radiotherapy & Oncology. 103(Supplement 1):S305. Available from: 10.1016/S0167-8140(12)71120-9

MLA

Vancouver

Serup-Hansen E, Hendel HW, Johannesen HH, Ottosson W, Kristensen B, Hollensen C et al. Analysis of Target Volume Definition Using CT, MRI and FDG-PET in Radiotherapy Treatment Planning of Anal Cancer. Radiotherapy & Oncology. 2012;103(Supplement 1):S305. Available from: 10.1016/S0167-8140(12)71120-9

Author

Serup-Hansen, E.; Hendel, H. Westergreen ; Johannesen, H. Hjorth ; Ottosson, W.; Kristensen, B.; Hollensen, Christian; Persson, G. Fredberg ; Geertsen, P. F. ; Havsteen, H. / Analysis of Target Volume Definition Using CT, MRI and FDG-PET in Radiotherapy Treatment Planning of Anal Cancer.

In: Radiotherapy & Oncology, Vol. 103, No. Supplement 1, 2012, p. S305.

Publication: Research - peer-reviewConference abstract in journal – Annual report year: 2012

Bibtex

@article{e00f81c426544199ad3c701771590016,
title = "Analysis of Target Volume Definition Using CT, MRI and FDG-PET in Radiotherapy Treatment Planning of Anal Cancer",
publisher = "Elsevier Ireland Ltd",
author = "E. Serup-Hansen and Hendel, {H. Westergreen} and Johannesen, {H. Hjorth} and W. Ottosson and B. Kristensen and Christian Hollensen and Persson, {G. Fredberg} and Geertsen, {P. F.} and H. Havsteen",
year = "2012",
doi = "10.1016/S0167-8140(12)71120-9",
volume = "103",
number = "Supplement 1",
pages = "S305",
journal = "Radiotherapy & Oncology",
issn = "0167-8140",

}

RIS

TY - ABST

T1 - Analysis of Target Volume Definition Using CT, MRI and FDG-PET in Radiotherapy Treatment Planning of Anal Cancer

A1 - Serup-Hansen,E.

A1 - Hendel,H. Westergreen

A1 - Johannesen,H. Hjorth

A1 - Ottosson,W.

A1 - Kristensen,B.

A1 - Hollensen,Christian

A1 - Persson,G. Fredberg

A1 - Geertsen,P. F.

A1 - Havsteen,H.

AU - Serup-Hansen,E.

AU - Hendel,H. Westergreen

AU - Johannesen,H. Hjorth

AU - Ottosson,W.

AU - Kristensen,B.

AU - Hollensen,Christian

AU - Persson,G. Fredberg

AU - Geertsen,P. F.

AU - Havsteen,H.

PB - Elsevier Ireland Ltd

PY - 2012

Y1 - 2012

N2 - Purpose/Objective: The main objectives were to explore the intermodality and intra-observer variations of anal cancer GTV delineations on CT, MRI and PET images.<br/><br/>Materials and Methods: 22 patients with biopsy-proven anal carcinoma scheduled for curative RT underwent FDG-PET/contrast enhanced CT and MRI. The delineations of GTV were done twice for each imaging modality with a minimum of 3 months in between. Delineations on the CT and MRI were done by routine methods. For the PET part three different cut-off values were used: SUV 2.5, 40% and 50% of maximum SUV, respectively. The GTVs were compared for: size, volume changes, center-of-mass (COM) and non-overlapping regions, regarding inter-modality and intra-observer variations. Wilcoxon rank sum test and ANOVA analysis were used, where p &lt; 0.05 was considered significant.<br/><br/>Results: 1. Volume size: The mean GTV-CT of the 1st and 2nd delineation was significantly larger compared to the mean GTV-MRI and the median GTVs from the different PET cut-offs (33.9 cm3, 18.0 cm3, 15.6 cm3, 14.8 cm3 and 10.3 cm3, respectively). The intraobserver differences in voluma size were small and non-significant. It was additionally found that the mean GTV-CT increased when overlaying either mean GTV-MRI or one of the three mean GTV-PETs (17%, 24%, 56% and 36 %, respectively). 2. COM: The inter-modality differences in COM were found to be &gt; 1cm between CT-MRI, CT-PET2.5 and MRI-PET2.5. However, the intraobserver differences in COM were found to be minor. 3. Non-overlap: There were significant differences in mean of the non-overlapping regions using the CT or MRI (20.5% and 22.5%) compared to the different PET cut-offs (5.5%, 6.4% and 5.8%), respectively.<br/><br/>Conclusions: Delineations of anal tumors are difficult. GTV-CT was the largest compared to GTV-MRI and the different GTV-PETs. Although the GTV-CT were larger, it did not always cover the GTVs of MRI and PET. The GTV-CT increased if overlaying GTV-MRI or one of the GTV-PETs. Based on our study, our recommendations are not to use CT solely for delineating anal tumors; MRI or PET should be considered as a second imaging modality.

AB - Purpose/Objective: The main objectives were to explore the intermodality and intra-observer variations of anal cancer GTV delineations on CT, MRI and PET images.<br/><br/>Materials and Methods: 22 patients with biopsy-proven anal carcinoma scheduled for curative RT underwent FDG-PET/contrast enhanced CT and MRI. The delineations of GTV were done twice for each imaging modality with a minimum of 3 months in between. Delineations on the CT and MRI were done by routine methods. For the PET part three different cut-off values were used: SUV 2.5, 40% and 50% of maximum SUV, respectively. The GTVs were compared for: size, volume changes, center-of-mass (COM) and non-overlapping regions, regarding inter-modality and intra-observer variations. Wilcoxon rank sum test and ANOVA analysis were used, where p &lt; 0.05 was considered significant.<br/><br/>Results: 1. Volume size: The mean GTV-CT of the 1st and 2nd delineation was significantly larger compared to the mean GTV-MRI and the median GTVs from the different PET cut-offs (33.9 cm3, 18.0 cm3, 15.6 cm3, 14.8 cm3 and 10.3 cm3, respectively). The intraobserver differences in voluma size were small and non-significant. It was additionally found that the mean GTV-CT increased when overlaying either mean GTV-MRI or one of the three mean GTV-PETs (17%, 24%, 56% and 36 %, respectively). 2. COM: The inter-modality differences in COM were found to be &gt; 1cm between CT-MRI, CT-PET2.5 and MRI-PET2.5. However, the intraobserver differences in COM were found to be minor. 3. Non-overlap: There were significant differences in mean of the non-overlapping regions using the CT or MRI (20.5% and 22.5%) compared to the different PET cut-offs (5.5%, 6.4% and 5.8%), respectively.<br/><br/>Conclusions: Delineations of anal tumors are difficult. GTV-CT was the largest compared to GTV-MRI and the different GTV-PETs. Although the GTV-CT were larger, it did not always cover the GTVs of MRI and PET. The GTV-CT increased if overlaying GTV-MRI or one of the GTV-PETs. Based on our study, our recommendations are not to use CT solely for delineating anal tumors; MRI or PET should be considered as a second imaging modality.

U2 - 10.1016/S0167-8140(12)71120-9

DO - 10.1016/S0167-8140(12)71120-9

JO - Radiotherapy & Oncology

JF - Radiotherapy & Oncology

SN - 0167-8140

IS - Supplement 1

VL - 103

SP - S305

ER -